Recent Finacing
Recent Raise
Enlaza Therapeutics develops covalent protein therapeutics using its War-Lock platform to site-specifically introduce unnatural amino acids, creating covalent warheads adaptable to ADCs and radioligand therapies for oncology.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
